GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anhui Liuguo Chemical Co 600470.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

4.74

-1.25%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2024

Revenue

CN¥6.25bn

FY2015FY2024

Net income

CN¥25.2m

FY2015FY2024

Free cash flow

−CN¥51.2m

FY2015FY2024

Shareholders' equity

CN¥1.83bn

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueCN¥6.25bnCN¥6.93bnCN¥7.55bnCN¥5.98bnCN¥4.82bnCN¥4.35bnCN¥4.17bnCN¥3.96bnCN¥4.46bnCN¥5.58bn
Gross profitCN¥554.2mCN¥536.8mCN¥808.3mCN¥863.1mCN¥636.1mCN¥311.3mCN¥493.7mCN¥594.0mCN¥265.7mCN¥627.4m
Research and developmentCN¥206.8mCN¥201.2mCN¥207.1mCN¥162.3mCN¥130.9mCN¥117.0mCN¥113.0mCN¥9.9mCN¥111.7mCN¥127.6m
Operating incomeCN¥57.4mCN¥60.6mCN¥239.4mCN¥343.9mCN¥201.4m−CN¥260.2m−CN¥397.1mCN¥29.1m−CN¥226.3mCN¥56.8m
Net incomeCN¥25.2mCN¥22.8mCN¥191.2mCN¥237.3mCN¥168.0m−CN¥262.0m−CN¥604.0mCN¥75.6m−CN¥124.6mCN¥148.8m
Diluted earnings per share0.070.040.370.440.33-1.86-1.43-2.35-0.240.30

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsCN¥7.03bnCN¥5.91bnCN¥7.00bnCN¥5.37bnCN¥4.52bnCN¥4.63bnCN¥5.77bnCN¥5.51bnCN¥5.84bnCN¥6.18bn
Cash and short-term investmentsCN¥1.33bnCN¥1.02bnCN¥2.15bnCN¥681.6mCN¥550.0mCN¥430.4mCN¥664.1mCN¥417.1mCN¥646.5mCN¥589.0m
Total liabilitiesCN¥4.87bnCN¥3.96bnCN¥5.08bnCN¥3.71bnCN¥3.18bnCN¥3.50bnCN¥4.38bnCN¥3.56bnCN¥3.92bnCN¥4.02bn
DebtCN¥1.92bnCN¥1.52bnCN¥2.91bnCN¥1.50bnCN¥1.49bnCN¥1.61bnCN¥1.98bnCN¥1.59bnCN¥1.72bnCN¥1.99bn
Shareholders' equityCN¥1.83bnCN¥1.81bnCN¥1.80bnCN¥1.61bnCN¥1.37bnCN¥1.18bnCN¥1.44bnCN¥2.07bnCN¥2.00bnCN¥2.16bn
Shares outstanding370m563m513m543m508m141m423m—511m488m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operationsCN¥388.6mCN¥446.5mCN¥426.5mCN¥476.1mCN¥143.1mCN¥315.1mCN¥63.5mCN¥162.6mCN¥565.5mCN¥165.7m
Capital spending−CN¥439.8m−CN¥532.9m−CN¥296.1m−CN¥162.2m−CN¥76.3m−CN¥92.5m−CN¥368.8m−CN¥276.2m−CN¥147.4m−CN¥130.5m
Free cash flow−CN¥51.2m−CN¥86.3mCN¥130.4mCN¥313.9mCN¥66.8mCN¥222.6m−CN¥305.3m−CN¥113.6mCN¥418.1mCN¥35.2m
Dividends paid−CN¥64.7m−CN¥66.3m−CN¥50.5m−CN¥54.2m−CN¥75.1m−CN¥104.3m−CN¥138.8m−CN¥96.0m−CN¥158.4m−CN¥138.9m

Latest quarters

By quarter end

Sept 2026Jun 2026Mar 2026Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.39bnCN¥1.45bnCN¥1.50bnCN¥1.85bnCN¥1.55bnCN¥1.60bnCN¥1.43bnCN¥1.76bn
Gross profitCN¥101.7mCN¥99.0mCN¥50.0mCN¥175.9mCN¥44.7mCN¥67.4mCN¥76.5mCN¥174.7m
Operating income−CN¥33.1m−CN¥34.6m−CN¥69.7m−CN¥17.1m−CN¥76.1m−CN¥55.0m−CN¥18.4mCN¥22.8m
Net income−CN¥101.6m−CN¥80.3m−CN¥90.4m−CN¥58.1m−CN¥82.5m−CN¥66.7m−CN¥13.2mCN¥9.0m
Diluted earnings per share-0.19-0.15-0.17-0.11-0.16-0.13-0.040.02
Cash from operations———CN¥456.0m−CN¥336.0m−CN¥61.0m—CN¥351.0m
Capital spending−CN¥479.0m−CN¥417.0m−CN¥470.0m−CN¥350.0m−CN¥325.0m−CN¥138.0m−CN¥240.0m−CN¥80.0m
Free cash flow———CN¥106.0m−CN¥661.0m−CN¥199.0m—CN¥271.0m
Total assetsCN¥9.82bnCN¥9.14bnCN¥8.53bnCN¥7.37bnCN¥6.89bnCN¥6.43bnCN¥7.03bnCN¥6.74bn
Cash and short-term investments———CN¥1.25bnCN¥974.9mCN¥975.1mCN¥1.33bnCN¥1.43bn
DebtCN¥2.83bnCN¥2.06bnCN¥1.62bnCN¥2.72bnCN¥2.29bnCN¥1.84bnCN¥1.90bnCN¥1.91bn
Shareholders' equityCN¥1.35bnCN¥1.45bnCN¥1.52bnCN¥1.63bnCN¥1.69bnCN¥1.77bnCN¥1.83bnCN¥1.85bn

Financial ratios

Data as of 22 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin—8.9%7.7%10.7%14.4%13.2%7.2%
Operating margin—2.1%1.9%4.6%6.1%5.6%-3.5%
Net margin—0.4%0.3%2.5%4.0%3.5%-6.0%
Return on equity—1.4%1.3%10.6%14.7%12.2%-22.3%
Return on assets—0.4%0.4%2.7%4.4%3.7%-5.7%
Free cash flow yield—44.2%34.3%27.8%23.2%8.5%57.0%
Revenue growth—-9.8%-8.2%26.2%24.1%10.8%4.5%
Earnings growth—10.7%-88.1%-19.4%41.3%-164.1%-56.6%
Current ratio—0.87x0.83x0.92x0.75x0.59x0.51x
Debt to equity—1.04x0.83x1.30x0.88x1.11x1.55x
Equity ratio—26.1%30.6%25.8%30.0%30.4%25.4%
Interest coverage—1.98x1.97x5.06x6.16x3.37x-1.30x
R&D as a share of sales—3.3%2.9%2.7%2.7%2.7%2.7%
Buybacks as a share of market value-42.2%34.3%-9.8%5.5%-6.8%-259.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.5%7.5%1.7%
Operating income-44.9%——
Net income-52.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin8.3%10.3%10.3%10.0%
Operating margin0.9%2.6%1.8%-0.5%
Net margin0.4%1.8%1.1%-0.6%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings80.2144.416.516.212.6-2.3-2.6-2.4-34.937.3
Price to sales0.30.50.40.60.40.10.4-0.11.01.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 22 Jun 2018.

FY2018FY2016FY2014FY2013FY2012FY2011FY2009FY2007
Paid in the year0.050.080.100.100.100.0940.0750.069
  • 8-for-5 split · 16 Jun 2011
  • 1-to-1 reverse split · 18 Apr 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.